Experimental systemic amyloidosis induced by immunization with syngeneic organ extracts in mice by unknown
EXPERIMENTAL 
IMMUNIZATION 
SYSTEMIC  AMYLOIDOSIS  INDUCED  BY 
WITH  SYNGENEIC  ORGAN  EXTRACTS 
IN  MICE 
BY  YOSHIO MORI,  BUNSHIRO AKIKUSA,*  TERUO MORI,  SHIRO UEDA, 
KENJI  IESATO,  HIROMICHI  YOSHIDA,  MAKOTO OGAWA,  ISAO KATO, 
YOKO WAKASHIN,  MASAFUMI  WAKASHIN,  AND  KUNIO OKUDA 
From the First Department of Medicine and the *Second Department of Pathology, Chiba 
University School of Medicine, Chiba, Japan 
The exact pathogenesis of amyloidosis is not yet understood, and a number of 
attempts have been made to produce amyloidosis in animals. Casein was the first 
substance found capable of inducing amyloidosis in animals (1), and subsequently 
several  other  animal  models  have  been  developed  (2-7).  In  the  induction  of 
amyloidosis  in  these  animal  models,  certain  agents  have  been  investigated  as 
accelerating factors for deposition of amyloid (8-11), or as blocking agents (12). 
More recently, reactions of cellular immunity involving T, B, and other immu- 
nological cells have been evaluated in the mechanism  of amyloid deposition in 
animals  (13-19).  Transfer  studies  have  also  been  reported  using  a  model  of 
experimental amyloidosis in animals (20, 21). 
In these studies, exogenous immunogens were used; syngeneic tissue substances 
have not as yet been used.  We have been able to produce systemic amyloidosis 
in mice by immunizing with syngeneic organ (liver or kidney) extracts and CFA. 
This model will throw some light on the pathogenesis of amyloidosis. 
Materials and  Methods 
Induction  of Systemic Amyloidosis.  6-wk-old male mice of strains C57BL/6 (B6, H-2b), 
BALB/c (H-2d), and C3H/He (H-2  k) were used. Fresh liver or kidney of each strain was 
homogenized and a 100,000 g supernatant was used as an immunogen. Immunization was 
performed within 24 h of preparation. 20 male mice of each strain were intramuscularly 
immunized six times at weekly intervals with 0.1  mi of the supernatant containing 10 mg 
of protein and an equal volume of CFA. As the control, another 20 mice of each strain 
were given syngeneic mouse sera (10 mg of protein) and CFA, or CFA alone, six times at 
weekly intervals. Another 20 mice of each strain were given the liver or kidney extract 
alone every second day for 6 wk, and histological examination was performed 7 d after 
the last injection. 
Histological Examination.  At 7 d, 14 d, 1 mo, 2 too, and 3 mo after the final injection, 
animals were killed, and specimens of the liver, kidney, spleen, brain, heart, stomach, and 
intestine were taken  for histological examination.  These specimens were checked  for 
deposition of amyloid by hematoxylin and eosin staining, Congo-red birefringence and 
electron microscopy. The grade of amyloid deposit was  scored as follows.  In  liver: -, 
negative; +,  mild amyloid deposit; +,  quantity of amyloid deposit in the hepatocyte is 
<50% of the average size of the hepatocyte in section; ++, quantity of amyloid deposit is 
between 50% and  100% of the size of hepatocytes in section; +++, quantity of amyloid 
deposit is about equal to the size of hepatocytes; and ++++, quantity of amyloid deposit 
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is larger than  the average size of hepatocytes.  In kidney: -,  negative;  +,  mild amyloid 
deposit;  +,  <10%  of glomeruli  containing amyloid deposit;  ++,  10-50%  of glomeruli 
containing amyloid; +++,  50%  of glomeruli  containing amyloid, some having marked 
amyloid deposition; ++++, all of glomeruli having marked amyloid deposition. The grade 
of amyloid deposition  in  the  spleen  was judged  in  the  same  way; it was graded  by the 
number (area on a section) of affected spleen cells and the amount of amyloid deposit. 
Characterization  of Amyloid  Deposit.  Amyloid deposit  in  each  organ  obtained  from 
amyloidotic B6 mice was checked using an anti-mouse amyloid protein  (AA)  ~ antibody. 
A piece of tissue was removed from the liver, kidney, spleen, and other organs of B6 mice 
immunized with liver extracts and CFA six times at weekly intervals. These fresh, frozen 
organ  tissues  were checked by indirect  immunofluorescence using monoclonal rat  IgG 
culture supernatant  antibody against  mouse AA and anti-rat  IgG goat IgG conjugated 
with FITC. As a control, anti-rat IgG goat IgG conjugated with FITC was used on each 
specimen by the direct immunofluorescence study.  Monoclonal anti-mouse AA rat IgG 
culture  supernatant  was  kindly  provided  by  Prof.  Shunsuke  Migita,  Cancer  Research 
Institute,  Kanazawa  University,  Kanazawa.  AA was purified  from B6  mice immunized 
with syngeneic liver extract and CFA six times at weekly intervals by the method of Pras 
et al.  (22) and  Isersky et al.  (23).  Native amyloid fibril  was prepared  from amyloidotic 
mice by the  combination  of homogenization and  centrifugation.  These  materials  were 
denatured  with  6  M  guanidine-HC1  and  used  as  denatured  amyloid  protein  (DAP). 
Antigenic reactivity of DAP derived  from B6  mice immunized  with  liver  extracts  and 
CFA was checked  with  monoclonal anti-mouse  AA antibody by the  immunodiffusion 
method. 
Fractionation  of Sensitized  and  Nonsensitized  Spleen  Cells from  Donor  Mice  and  Their 
Transfer.  Immediately after killing,  spleen  cells of donor mice, in which systemic amy- 
loidosis had been induced by injecting liver extracts and CFA, or of control animals were 
separated using a stainless steel mesh (No. 200, Abe Science Co., Chiba, Japan). A portion 
of them was passed through a nylon-wool column and separated into nylon-wool column 
nonadherent (T-enriched) cells and nylon-wool column adherent cells, using RPMI  1640 
(Gibco Laboratories, Grand Island, NY) with  10%  FCS calf serum (Gibco Laboratories). 
After separation,  these spleen  cells were resuspended  in HBSS.  1-5 ×  107 cells of each 
fraction of sensitized and control spleen cells were injected into the tail veins of untreated 
recipient mice. To assess the quantities of amyloid deposit in the organs of recipient mice, 
histological examination of the liver, kidney, and spleen  was carried out by killing them 
at 48 h, 7 d,  14 d,  1 mo, 2 mo, and 3 mo after the injection. 
Treatment  of Sensitized  Spleen  Cells  with  Anti-Thy-l,2;  Anti-Ly-1;  and  Anti-Ly-2  Anti- 
body.  Nylon-wool column adherent spleen cells obtained from donor mice were treated 
with anti-Thy-1,2 mAb (clone F7D5; Olac 1976 Ltd., Blackthon Bicester Oxon, England) 
and  Low-Tox-M  rabbit  complement  (Olac).  1-5  x  107  of the  sensitized  nylon-wool 
adherent  cells were  treated  with  anti-Thy-l,2  antibody, placed  on ice for 45  min,  and 
washed three times with HBSS. The cells were then treated with rabbit complement for 
45 min at 37 o  C. After washing three times,  1-5 x  107 of treated cells were injected into 
20 normal B6 recipient mice. As a control, another set of sensitized nylon-wool adherent 
cells  was  treated  with  either  anti-Thy-l,2  antibody  or  rabbit  complement  alone,  and 
injected  into  20  normal  B6  mice.  These  animals  were  killed  2  mo after  injection  for 
histological  examination.  Furthermore,  1-5  x  107  adherent  cells  of donor  mice  were 
treated by the combination of anti-mouse Ly-1 or Ly-2 rat 3'-globulin (Fab fraction), anti- 
rat mouse 3'-globulin (MAR), and rabbit complement. These cells were transferred to 20 
normal  recipient  mice,  and  histological  examination  was  performed  2  mo  after  the 
injection. These anti-Ly-1, anti-Ly-2, and MAR were kindly provided by Dr. Takemori, 
Department  of Immunology,  Institute  of Environmental  Health,  School  of Medicine, 
Chiba University, Chiba. 
Pathogenetic Investigation  of Liver Extract with Various  Treatments.  Liver extract of B6 
mice was treated  by various methods,  then  the treated  immunogen was checked for its 
ability  to induce systemic amyloidosis.  Each of these  immunogens containing  10 mg of 
1 Abbreviations used in this paper:  AA, amyloid protein; DAP, denatured amyloid protein. MORI  ET  AL.  1555 
TABLE  I 
Induction of Systemic Amyloidosis in Mice Immunized with Liver Extract and CFA 
Exp.  Pathogen 
Number  Histological findings* 
examined  _  +  +  ++  +++  ++++ 
Liver extract* +  CFA: 
BALB/c  20  0  4  5  6  5  -- 
C3H/He  20  0  2  8  6  4  -- 
C57BL/6  20  0  0  0  4  11  5 
Normal serum from mice of each 
strain  "~ +  CFA: 
BALB/c  20  13  5  2  -- 
C3H/He  20  11  5  3  1 
C57BL/6  20  12  4  2  2 
m 
i 
FCA alone: 
BALB/c  20  20  --  --  -- 
C3H/H  20  14  5  1  --  --  -- 
C57BL/6  20  19  1  .... 
* Grade of amyloid deposit in liver was determined as described in Materials and Methods. 
* 10 mg protein/mouse. 
protein was injected with CFA six times at weekly intervals, and histology was examined 
7 d after the final injection. The grade of amyloidosis in each group was determined by 
the quantities of amyloid deposited in the liver. 
The liver extract was separated into a  microsomal fraction and a  supernatant after 
100,000 g centrifugation for 60 min, and an amount of each fraction that contained 10 
mg of protein was injected with CFA into normal B6 mice six times at weekly intervals, 
and histological changes were studied 7 d after the last injection. Since this supernatant 
had a greater capability of inducing systemic amyloidosis than the microsomal fraction, 
further study was carried out using 100,000 g supernatant. The supernatant was treated 
either by freezing and thawing three times, then was lyophilized or digested by  10% 
trypsin (from bovine pancreas, Sigma Chemical Co., St. Louis, MO) at 37°C for 30 rain. 
After these treatments the immunogen or the treated supernatant was intramuscularly 
injected with CFA six times, and histological examination was done 7 d  after the last 
injection. 
Results 
Systemic Amyloidosis  Induced by Syngeneic Organ Extracts.  Table I shows histo- 
logical findings regarding amyloid deposition in the liver of mice injected with 
100,000  g  supernatant  of  syngeneic  liver  extract  and  CFA.  The  grade  of 
amyloidosis was determined by the amount of deposit in the liver. C57BL/6 (B6) 
mice injected with liver extract and CFA revealed the most prominent amyloid 
deposition  in  their  organs,  followed by  BALB/c and  C3H/He  mice.  Fig.  1 a 
shows liver histology in a  B6 mouse injected with liver extract and CFA, using 
marked deposition of amyloid in the lobule. The quantity of amyloid deposition 
was larger than the average size of hepatocytes in section. Fig. 1 b shows birefrin- 
gence of liver sections stained with Congo red in a  B6 injected once with liver 
extract. An electron micrograph of the liver with amyloid deposition as shown 
in Fig. 2, clearly shows amyloid fibrils. Fig. 3 shows deposition of amyloid in the 
spleen  of mice  injected with  liver extract.  As  controls,  normal  serum  of each 1556  EXPERIMENTAL  AMYLOIDOSIS  IN  MICE 
FIGURE  1.  (A) Liver of C57BL/6 (B6) mouse immunized six times with a  liver extract and 
CFA (H & E, x  250).  Marked amyloid deposition is seen within the liver lobule. (B) Liver of 
B6 mouse immunized with liver extract and CFA (Congo-red birefringence, x  250). 
strain with CFA or CFA alone was injected in the same way, and histology was 
examined 7 d after the final injection. In the organs of control animals, amyloid 
deposition  was  negative  or  minimal  compared  with  those  injected  with  liver 
extract mixed with CFA. 
A  100,000  g  supernatant  of B6  kidney  extract  mixed  with  CFA  was  also 
injected to 20 B6 mice in exactly the same way and histological examination was 
made.  As  shown  in  Table  II,  deposition  of amyloid in  the  liver  of B6  mice 
injected with  a  liver extract was  more prominent compared with  the  liver of MORI  ET  AL.  1557 
FIGURE 2.  Electron micrograph of the liver of C57BL/6 (B6) mouse showing amyloid fibrils 
(× 40,000). 
FIGURE 3.  Spleen of C57BL/6 (B6) mouse immunized six times with a liver extract and CFA 
(H & E, x 250). Marked amyloid deposition is seen. 
mice given a  kidney extract and  CFA.  Similarly,  deposition of amyloid  in  the 
kidney of mice injected with  kidney extract was  more marked  compared  with 
mice injected with a  liver extract and CFA. This seems to suggest partial organ 
specificity in the production of amyloidosis in the liver and kidney. Fig. 4 a  shows 
a hematoxylin-eosin stain of the kidney of B6 mice given a  100,000 g supernatant 
of the kidney extract and CFA six times.  Prominent amyloid deposition is seen 1558  EXPERIMENTAL  AMYLOIDOSIS  IN  MICE 
TABLE  II 
Induction of Systemic Amyloidosis in C57BL/6 Mice Injected with Syngeneic Liver or Kidney 
Extract and CFA 
Exp.  Immunogen  Histology  Number 
of:  examined 
Histological findings* 
+  ++  +++  ++++ 
1  Liver extract*+CFA  Liver  20  --  5  12  3 
Kidney  20  5  10  5  -- 
Spleen  20  --  12  8  -- 
2  Kidney extract* +  CFA  Liver  20  1  14  5  -- 
Kidney  20  6  2  6  6 
Spleen  20  5  14  1  -- 
* Grade of amyloid deposit was determined as described in Materials and Methods. 
* 10 mg protein/mouse. 
particularly in all glomeruli of the immunized mice. Fig. 4 b shows birefringence 
of Congo-red stain in the kidney. The liver or kidney extract alone was capable 
of inducing amyloidosis without CFA,  although  the deposition  was much less 
pronounced in degree (Table III). Quick-frozen sections of organs of B6 mouse 
with amyloid deposit was checked with a monoclonal anti-mouse AA antibody. 
Fig.  5,  a  and b show positive immunofluorescence of AA in  liver and  kidney 
specimens, respectively. In an immunodiffusion study, DAP extracted from the 
liver of amyloidotic B6 mice reacted with monoclonal anti-mouse AA antibody. 
Transfer of Spleen  Cells of Donor Mice  to Recipient Mice.  Using a  nylon-wool 
colunm, spleen cells of immunized donor mice and control animals were sepa- 
rated into adherent and  nonadherent cells.  Each  fraction of spleen  cells and 
unseparated whole spleen cells were injected into normal recipient B6 mice via 
a tail vein, and histology was examined at intervals. Although no changes were 
seen  in  the organs  of recipient  mice  until  1  mo  after  the  transfer,  systemic 
amyloidosis became apparent in the recipient mice 2 mo after the injection. The 
most prominent histological changes were found in the organs of recipient mice 
injected with nylon-wool adherent spleen cells (Table IV).  As shown in Table 
IV,  no significant histological  change occurred in  the recipient mice injected 
with spleen cells of control animals. 
Treatment  with Anti-Thy-l,2,  Anti-Ly-l,  and  Anti-Ly-2  Antibodies  and  Comple- 
ment.  As the data in Table  IV show, the column adherent spleen cells of B6 
mice injected with liver extract and CFA induced the most prominent amyloidosis 
in recipient mice 2 mo after injection. Those primed adherent spleen cells were 
treated with anti-Thy-l,2 monoclonal antibody and complement to deplete T 
cells, and treated adherent cells were injected into normal B6 mice followed by 
histological examination. As shown in Table V, amyloidosis was much less severe 
in  mice injected with  spleen cells treated by the combination of anti-Thy-l,2 
antibody and complement. Further study using anti-Ly-1  and  Ly-2 antibodies 
showed that this treatment completely abolished the amyloidosis inducing effect 
of primed adherent spleen cells. 
Pathogenetic  Study  of Immunogen  in  Liver.  A  study  was  carried  out  with 
fractions of the liver extract to determine the active factor in the immunogen. MORI  ET  AL.  1559 
FIGURE 4.  (A) Kidney of C57BL/6 (B6) mouse immunized six times with kidney extract and 
CFA (H & E, × 250). Marked amyloid deposition is seen in the glomeruli. (B) Kidney of B6 
mouse immunized with liver extract and CFA (Congo-red birefringence, x 250). 
As shown in Table VI, the supernatant of liver extract and a microsomal fraction 
in an amount equivalent to  10 mg protein was used as the immunogen six times 
at  weekly intervals,  and  histological  examination  was  performed  7  d  after  the 
final  injection.  The ability  to induce  amyloidosis was stronger  with  the  soluble 
liver fraction  (100,000  g  supernatant)  than  with  the  microsomal  fraction.  The 
100,000  g  supernatant  of liver extract was further treated by various methods, 
as given in Table VI. When  the immunogen was stored at 4°C,  its amyloidosis- 
inducing  activity was maintained  for 24  h,  but  was nearly  lost after 72  h.  The 1560  EXPERIMENTAL  AMYLOIDOSIS  IN  MICE 
TABLE  III 
Induction  of Systemic Amyloidosis in C57BL/6 Mice Injected with Syngeneic 
Kidney or Liver Extract Alone 
Histology  Number 
Exp.  Immunogen  of:  examined 
Histological findings* 
-  ±  +  ++ 
1  Liver extract*  Liver  20  2  9  9  -- 
Kidney  20  10  10  --  -- 
Spleen  20  --  2  12  6 
2  Kidney extract*  Liver  20  4  1  15  -- 
Kidney  20  5  0  15  -- 
Spleen  20  4  1  1  14 
* Grade of amyloid deposit was determined as described in Materials and Methods. 
* 10 mg protein/mouse. 
activity of the supernatant was lost after freezing and thawing more than three 
times;  both  lyophilization and  trypsin  digestion  destroyed the activity almost 
completely. 
Discussion 
Experimental amyloidosis has been induced in  mice with casein, but  15-30 
injections are required (1-3, 5, 7, 8,  15-17,  20, 21, and 24). Other investigators 
produced amyloidosis by injecting CFA (4), bacteria (25), endotoxin of Escherichia 
coli (5 and 6), or by radiation (8). In these animal models, amyloidosis is induced 
by a substance that does not exist in animal body, or by a physical means. Our 
study is the first demonstration of systemic amyloidosis produced by substances 
contained  in  the  animal  organs,  namely,  syngeneic  liver  or  kidney  extract, 
together with  CFA given only six  times at weekly intervals.  All mice injected 
with these syngeneic organ extracts and CFA showed a  marked deposition of 
amyloid, mainly in the liver and kidney followed by the spleen.  Furthermore, 
partial organ specificity was shown with these extracts. Using a monoclonal anti- 
mouse AA antibody, it was shown that the deposited material was mouse AA. In 
this animal model, CFA may act as an enhancing factor like irradiation (9),  or 
an amyloid-enhancing factor described by Axelrad et al. in animal tissues (11), 
since deposition of amyloid was much less pronounced in degree in the animals 
injected with  liver or  kidney extract without  CFA.  Control  animals  similarly 
given sera of syngeneic animals and CFA or CFA alone showed negative results 
or only a  minimal histological change. These data seem to indicate that patho- 
genetic substances are contained in  these  organs,  and  that  they are partially 
organ-specific. Analysis of the putative pathogenetic substance contained in  a 
100,000 g supernatant of the liver extract suggested that its characteristics are: 
(a) easily degraded by freezing and thawing, or lyophilization; (b) stable at 4°C 
for 24 h; and (c) digested by trypsin. The amyloidosis inducing substance in liver 
extract might be composed of unstable proteins or protein-bound substances. 
In  the mouse strains (C57BL/6,  C3H/He,  and BALB/c) used in this study, 
C57BL/6  (B6) Showed the most prominent systemic amyloidosis, followed by 
C3H/He and BALB/c. Strain differences in the occurrence of systemic amyloi- MORI  ET  AL.  1561 
FIGURE 5.  Indirect immunofluorescence study using a monoclonal anti-mouse AA antibody 
on liver (A) and kidney (B) specimens. Positive immunofluorescence of AA is seen. 
dosis have  been  reported  in  mice.  Hardt  et al.  reported  that amyloid deposit 
induced by casein  injection was more marked in C3H/He  and C57BL/6  mice 
(21).  Amyloid synthesis and accumulation in situ was studied, and involvement 
of mucoprotein, glycoprotein-producing periodic acid/Schiff-positive cells (26) 
or impaired Kupffer cells (27) has been suggested. Synthesis of serum amyloid 
protein (SAA) in hepatocytes has been demonstrated in casein-induced amyloid 
animals in  vivo and  in  vitro  (24,  28).  It  is  well  known that an  immunological 
mechanism  is  involved  in  the  pathogenesis  of secondary  amyloidosis.  In  the 
pathogenesis of amyloidosis, a  role  of plasma cells or their  precursors  (16),  B 1562  EXPERIMENTAL  AMYLOIDOSIS  IN  MICE 
TABLE  IV 
Induction of Systemic Amyloidosis in the Organs of Mice Injected with Primed Spleen Cells at 8 
wk After Transfer 
Number  Exp.  Fraction of spleen cells  examined 
Histological findings* 
--  +_  +  ++ 
Transfer of spleen cells of donor mice injected 
with liver extract +  CFA: 
Whole spleen cells  20  16  2 
Nylon wool column nonadherent ceils  20  17  1 
Nylon wool column adherent cells  20  3  1 
2 
1  1 
2  14 
Transfer of spleen cells of control mice injected 
with CFA alone: 
Whole spleen cells  20  20 
Nylon-wool column nonadherent cells  20  20 
Nylon-wool column adherent cells  20  20 
m 
* Grade of amyloid deposit was determined as described in Materials and Methods. 
TABLE  V 
Induction of Systemic Amyloidosis in the Organs of Recipient Mice Injected with 
Primed Nylon~Wool Column Adherent Spleen Cells Treated with Anti-Thy-l,2; 
Ly-1; Ly-2; and~or Complement 
Histological 
Treatment  Number  findings* 
examined 
--  _++  +  ++ 
No treatment  20  3  1 
Complement alone  20  8  2 
Anti-Thy-l,2 mAb alone  20  5  4 
Anti-Thy-l,2 mAb +  complement  20  17  3 
Anti-Ly-I rat anti-mouse 3,-globulin (Fab) +  mouse  20  18  2 
anti-rat 3,-globulin (MAR) 
Anti-Ly-2 rat anti-mouse -y-globulin (Fab) +  MAR  20  19  1 
+  complement 
2  14 
5  5 
8  3 
* Grade of amyloid deposition in liver was determined by the criteria in Materials and 
Methods. 
cell-macrophage  interaction  (17),  and  depletion of T  cell population  (18,  19) 
have been reported.  However, it is not known which set of cells is responsible 
for the induction of amyloidosis. 
In our transfer study, most prominent systemic amyloidosis occurred in recip- 
ient mice 2 mo after the transfer of nylon-wool adherent  spleen cells of donor 
mice.  Treatment  of these  adherent  cells  with  anti-Thy-l,2;  Ly-1;  and  Ly-2 
antibodies and complement abolished deposition ofamyloid, but a single antibody 
or  complement  alone  did  not.  These  data  seem  to  indicate  that  nylon-wool 
adherent  T  cells with  Ly-l+,2+,3 + phenotype of donor mice play an important 
role in the induction of systemic amyloidosis, and that these T  cells may work as 
helper  or  amplifier  cells.  In  some  reports,  it  was  suggested  that  interactions 
between T  cells with Ly-l+,2+,3 + and Ly-1 + cells was necessary for the manifes- 
tation  of the delayed-time hypersensitivity (DTH) response (29,  30).  This  may MOR!  ET  AL.  1563 
TABLE VI 
Systemic Amyloidosis Induced by Variously Treated Liver Extracts of C57BL/6 (B6) Mice 
Number  Histological findings in liver* 
Exp.  Immunogen*  examined  _  +  +  ++  +++  ++++ 
Fraction of B6 liver extract: 
Supernatant of 100,000 g centrifugation  °  20  0  0 
Microsomal fraction  §  20  0  0 
Treatment of supernatant of 100,000 g cen- 
trifugation of liver extractl: 
4°C for 24 h  20  0  0 
4°C for 72 b  20  4  4 
Freezing and thawing  |  20  18  2 
Lyophilization  20  3  5 
10% trypsin digestion  20  15  3 
0  5  12  3 
8  6  6  -- 
0  4  13  3 
12 
12 
2 
* Given with CFA six times at weekly intervals. 
* Grade of amyloid deposition was determined by the criteria in Materials and Methods. 
10 mg protein/mouse. 
I Over three times. 
suggest that induction of amyloidosis in recipient mice may be related to a cell 
to cell interaction of a delayed-type immunological reaction under our conditions. 
In  another study,  amyloid deposition  was  seen  in  an  early stage  in  B6  mice 
treated by 300  rad radiation to deplete suppressor cells (data not shown). This 
phenomenon was found in both donor and recipient mice. These data seem to 
indicate significant involvement of suppressor T  cells in the induction of amyloi- 
dosis in our model. Further studies would hopefully clarify the role of cellular 
immunity in the induction of amyloidosis in animals. 
Summary 
Systemic amyloidosis was induced consistently in mice by intramuscular injec- 
tion of syngeneic organ (liver and kidney) extracts mixed with CFA six times at 
weekly intervals. Syngeneic organ extract with CFA also induced amyloidosis of 
a  lesser degree. All  three strains  of mice (C57BL/6,  C3H/He,  and  BALB/c) 
injected  with  a  syngeneic  liver  extract  mixed  with  CFA  developed  systemic 
amyloidosis; the most prominent amyloid deposition occurred in C57BL/6 (B6) 
mice, followed by C3H/He and BALB/c.  The amyloid substance deposited in 
these animals was identified as mouse amyloid A protein (AA). Furthermore, an 
organ specificity of the immunogen in inducing amyloidosis was suggested with 
liver and kidney extracts. 
Primed spleen cells of the immunized B6 mice were fractionated by a nylon- 
wool column and injected to normal recipient mice via the tail vein. Organs of 
the recipient mice developed systemic amyloidosis 8  wk after the transfer, and 
the most prominent histological changes occurred in  the recipient mice given 
nylon-wool colunm adherent spleen cells. Using anti-Thy-l,2; Ly-1; Ly-2, anti- 
body and complement, it was suggested that T  cells, especially Ly-l,2,3  + T  cell 
populations in the primed nylon-wool adherent cells, play an important role in 
the induction of systemic amyloidosis. It was shown further that the amyloidosis- 1564  EXPERIMENTAL  AMYLOIDOSIS  IN  MICE 
inducing substance in liver extract was composed of unstable proteins or protein- 
bound substance. 
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